Jinhai Medical Technology Limited

As of December 31, 2025, Jinhai Medical Technology Limited carries a market capitalization of 6.61B, placing it among publicly traded companies globally. Its enterprise value stands at 6.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Jinhai Medical Technology Limited has 5.29B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Jinhai Medical Technology Limited maintains a current ratio of 1.84, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Jinhai Medical Technology Limited's stock has gained approximately 265.38% over the past 52 weeks. The 50-day moving average sits at 5.05, while the 200-day moving average is 3.47.

As of December 31, 2025, Jinhai Medical Technology Limited holds 222.78M in cash and equivalents against 90.30M in total debt, resulting in a net debt position of -143.04M. Total book value stands at 310.65M, with working capital of 178.19M providing operational flexibility.

Jinhai Medical Technology Limited's most recent stock split took place on December 31, 2024 with a 1:4 split ratio.